Your event should be here ! To publish, manage, promote... To learn or to be formed ... Online registrations

Site language : English - Français
Ref : 32352
Event :Microbiome Movement - Drug Development Europe 2021

Dates :Wednesday January 27th, 2021 - Friday January 29th, 2021

Location :Online (Internet, Videoconferencing, ...)

Type :Conference & Seminar - International audience

Accreditation :--


Further information

As the first microbiome-based therapeutic steps closer to market approval, the scientific community continue to demonstrate the functional role of the human microbiome as a novel source of therapeutic, biomarker and diagnostic development. Despite this progress, the vast potential to develop effective treatments that target the human microbiome is still limited by the complex challenges in developing them.
Part of the foremost conference series for microbiome researchers in industry, the 5th Microbiome Movement - Drug Development Europe 2021 will return to unite leading scientists from the biopharmaceutical and academic community to pursue the causal role of the microbiome in disease, and help create a new generation of microbiome-targeted therapeutics with predictable modes of action and consistent clinical outcomes.
Conference + 3 Workshops (Industry): GBP 2246.0,
Conference + 2 Workshops (Industry): GBP 1997.0,
Conference + 1 Workshop (Industry): GBP 1748.0,
Conference Only (Industry): GBP 1499.0,
Conference + 3 Workshops (Academic): GBP 1796.0,
Conference + 2 Workshops (Academic): GBP 1597.0,
Conference + 1 Workshop (Academic): GBP 1398.0,
Conference Only (Academic): GBP 1199.0,
Conference Only (Vendor): GBP 1799.0
Speakers: Vasily Fedorin, Director of Operations, 4BIO Capital, Marcus Rauch, Co-Founder and CSO, AlphaBiomics, Mark Bamforth, President and CEO, Arranta Bio, Prof Ted Dinan, Medical Director, Atlantia Food Clinical, Elran Haber, CEO, Biomica, Shiri Meshner, VP R and D, Biomica, Assaf Oron, Chief Business Officer, BiomX, Adrien Nivoliez, CEO, biose industrie, Kristofer Cook, CEO and Co-Founder, Carbiotix, Arne Materna, VP Product, Cosmos ID, Matthew Cummings, CEO and Co-Founder, CCBio, Sebastien Guery, Technology and Innovation Leader, DuPont Nutrition and Biosciences, Xavier Duportet, CEO, Eligo Biosciences, Gregoire Chevalier, Scientific Affairs Manager, Enterome, Benjamin Hadida, CEO and Co-Founder, Exeliom Biosciences, Mathilde Antoine, Operations Manager, Exeliom Biosciences, Alexandre Almeida, EBI-Sanger Postdoctoral Fellowship, European Bioinformatics Institute, Rob Finn, Head of Microbiome Informatics Team, European Bioinformatics Institute, Dirk Hadrich, Policy and Programme Officer, European Commission, Jenny Bailey, CEO and Co-Founder, Ferryx, Paul Carlson, Principal Investigator, CBER, Zain Kassam, CMO, Finch Therapeutics, Sam Minot, Staff Scientist Fred Hutchinson, Cancer Research Center, Craig Thompson, Partner, HGF Limited, Pamela Pruski, Research Associate, Imperial College London, Georges Rawadi, CEO, LNC Therapeutics, Tina Christensen-Ram, General Manager Quality, Luina Bio, Herve Affagard, Founder and CEO, MaaT Pharma, Lutz Kraus, Head of Data-Mining and Artificial Intelligence, Microba, Mike Romanos, CEO, Microbiotica, Trevor Lawley, CSO, Microbiotica, Mat Robinson, VP, Translational Biology, Sam Possemiers, CEO, MRM Health, Fabio Grassi, Founder, MVBiotherapeutics, Conrad Lichtenstein, CSO, Nemesis Bioscience, Stanislas Desjonqueres, CEO, Nexbiome Therapeutics, Mark Fitzgerald, Partner, Nixon Peabody LLP, Gregory Amos, Head of Microbiome Section, NIBSC, Alice Rounet, Regulatory Affairs Associate, Pharmabiotic Rese, Aurelien Baudot, Head of Business Development, ProDigest, Ken Blount, CSO, Rebiotix, Eric van der Helm, Head of Synthetic Biology and Bioinformatic, SNIPR Biome, Tomas de Wouters, CEO and Co-Founder, PharmaBiome, Todd de Santis, Co-Founder and VP Informatics, Second Genome, Matt Henn, CSO, Seres Therapeutics, Nicole McKnight, CEO, Stellate Therapeutics, Nikhil Sharma, MD Consultant Neurologist and Senior Clinical Researcher, UCL, Prof Sahar El Aidy, Department of Molecular Immunology and Microbiology, University of Groningen, Dr. Imke, Mulder Research Director, 4D Pharma, Kathleen Brennan, Director Microbiology, Boston Analytical
Time: 08:00 - 18:00

Further information

To access the information you need to be connected. Creating an account is easy and free!

Log to your account
Register on Doctorama


Microbiome Movement - Drug Development Europe 2021 Medicine
-- -- --

Recommend this event